Browser View | printer friendlyPrint PDF
Your Company
facebook youtube
January 2010
 
Publications
Dear Colleagues:
What's on My Mind Podcast
play button Listen! iTunesU link
small rss icon
Dean Reece

What’s on my mind this month is our new strategic plan, “Soaring to Greater Heights, Together.”

In November, nearly 100 leaders from the School of Medicine and the University of Maryland Medical Center/System gathered at the new University of Maryland Southern Management Campus Center for a day-long retreat. The goal of this brainstorming session was to identify opportunities and to generate new ideas to help us take a “quantum leap” within the next five years.

Committees have been working for over a year to develop roadmaps in the following areas: education, research, clinical care, community service and outreach and finance/philanthropy. Committee members met regularly to discuss, strategize and develop measurable goals and objectives for their specific areas. The resulting roadmaps formed the basis of the November retreat and were used as starting points to identify opportunities, ideas and approaches to assist in the development of a strategic plan that is bold, catalytic and ambitious.

At the retreat, I charged all participants to:

  • Review and identify changes to the roadmaps to include opportunities within and across the university and medical system,
  • Increase their personal commitment to the direction and success of the school, and
  • Become a supportive community of leaders and stakeholders that will facilitate the plan implementation.

These roadmaps are “living” documents, and work remains to be done to finalize these documents into one cohesive strategic plan. Small groups are being formed to update each roadmap based upon the discussion and feedback from the retreat. A final plan will be published next spring, and all board members, faculty, staff, fellows, residents and students will receive a copy. The University of Maryland School of Medicine’s 2010–2015 Strategic Plan, “Soaring to Greater Heights, Together,” is OUR strategic plan.

The School of Medicine has enormous opportunities to continue the momentum we have developed together. The retreat was an important step in our common understanding about the road ahead, but it was just one step. The remaining steps must be taken by all of us. Competition will be even stiffer as the school’s recognition continues to rise. We will have to be smarter and even more focused to sustain our accomplishments and growth.

The University of Maryland School of Medicine has already secured a place in the top tier of US medical schools through our creativity and the hard work of our faculty, staff and ardent supporters. We must continue at our strong pace, especially in these challenging times. Setting priorities and staying on the right track will help us to continue to strengthen our mission areas. The School of Medicine’s 2010–2015 strategic plan will be instrumental in elevating this medical school to the next level of achievement in research, education, clinical care and community service and outreach.

In the relentless pursuit of excellence, I am

Sincerely yours,

signature

E. Albert Reece, MD, PhD, MBA
Vice President for Medical Affairs, University of Maryland
John Z. and Akiko K. Bowers Distinguished Professor &
Dean, University of Maryland School of Medicine

 
Publications

Kevin Cullen, MD

Kevin Cullen

Kevin Cullen, MD, professor, Department of Medicine, and director, University of Maryland Marlene and Stewart Greenebaum Cancer Center, co-published “Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalance of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients” in the September 2009 issue of Cancer Prevention Research Journal.

Ashraf Badros, MD

Ashraf Badros

Ashraf Badros, MD, associate professor, Department of Medicine and Program in Oncology, co-published “Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed Multiple Myeloma” in the August 15, 2009, issue of Clinical Cancer Research.

Alan R. Shuldiner, MD

Alan Shuldiner
Alan R. Shuldiner, MD, John L. Whitehurst Professor of Medicine, published “Association of Cytochrome P450 2C19 Genotype with the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy” in the August 26, 2009, issue of the Journal of the American Medical Association.

Amy Fulton, PhD

Amy Fulton

Amy Fulton, PhD, professor, Department of Pathology and Program in Oncology, was a guest editor of the book Chemokine Receptors in Cancer, which was published by Humana Press, 2009.

Ronald Gartenhaus, MD

Ron Gartenhaus

Ronald Gartenhaus, MD, associate professor, Department of Medicine and Program in Oncology, published an article entitled “ERK Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma” in the October 1, 2009, issue of Cancer Research Journal.

Stephen B. Liggett, MD

Stephen Liggett

Stephen B. Liggett, MD, professor, Departments of Medicine and Physiology, co-authored “a2C-adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure” in the October 30, 2009, online version of Circulation: Heart Failure.

Leonid Medved, PhD,
and Sergiy Yakovlev, PhD


Leonid Medved

Leonid Medved, PhD (pictured), professor, and Sergiy Yakovlev, PhD, research associate, both from the Department of Biochemistry & Molecular Biology and Center for Vascular and Inflammatory Diseases, co-published “Interaction of fibrin(ogen) with Endothelial Cell Receptor VE-cadherin: Localization of the Fibrin-binding Site within the Third Extracellular VE-cadherin Domain” in Biochemistry, 2009 June 16;48(23):5171-9.

Shawn Robinson, MD,
and Elijah Saunders, MD


Shawn Robinson
Shawn Robinson, MD (pictured), assistant professor, and Elijah Saunders, MD, professor, both from the Department of Medicine, co-authored “Will Race Matter in the Era of Personalized Medicine?” in Cardiology Today, Volume 12, No. 9, September 2009.

Olga Ioffe, MD

Olga Ioffe, MD, associate professor, Department of Pathology and Program in Oncology, was a guest editor of a special issue of Pathology Case Reviews Journal entitled “Diagnostic Problems in Breast Pathology.”

 
Events

Melissa McDiarmid, MD, MPH

Melissa McDiarmid

Melissa A. McDiarmid, MD, MPH, professor, Department of Medicine, and director, Occupational Health Program, hosted the 10th Annual James P. Keogh Memorial Lecture in the Shock Trauma Auditorium in October 2009. This lecture is dedicated in memory of James P. Keogh, MD, who was associate professor of medicine and director of the Occupational Health Project from 1987 to 1999. He died in 1999 at the age of 49. Dr. Keogh worked tirelessly in the area of workplace hazards, set standards in the industry in the name of many blue-collar workers and was passionate about educating students, residents and physicians on the need to incorporate clinical compassion with public health prevention. This year’s lecture, “Chronic Beryllium Disease—How Often Are We Missing the Diagnosis?,” was given by Dr. Laura S. Welch, medical director of the Center for Construction Research and Training and adjunct professor at the George Washington University School of Public Health.

Philip A. Mackowiak, MD, MACP

Philip Mackowiak

Philip A. Mackowiak, MD, MACP, professor and vice chair, Department of Medicine, hosted a “Meet-the Professor” session with Dr. Jos van der Meer of Nijmegen University, the Netherlands, for the Infectious Diseases Society of America Annual Meeting in Philadelphia in October 20009. The session was entitled “Fevers and Fevers of Unknown Origin: Any New Tricks for the Trade?”

Ming T. Tan, PhD

Ming Tan

Ming T. Tan, PhD (pictured), professor, Department of Epidemiology & Preventive Medicine and Program in Oncology, presented “The Design and Analysis of Drug Synergy in Therapeutic Development: Applications to Vorinostat with Cystosine Arabinoside and Etopside and Other Combination Studies” at the National Cancer Institute’s Translational Science Meeting 2, held in Vienna, Virginia, in November 2009. His collaborators included Hongbin Fang, PhD, assistant professor, Department of Epidemiology & Preventive Medicine and Program in Oncology; and Douglas Ross, MD, PhD, professor; Martin Edelman, MD, professor; and Edward Sausville, MD, PhD, professor, all from the Department of Medicine and Program in Oncology.

Leonid Medved, PhD

Leonid Medved
Leonid Medved, PhD, professor, Department of Biochemistry & Molecular Biology and Center for Vascular and Inflammatory Diseases, was an invited speaker at the 34th Congress of the Federations of European Biological Societies in Prague, Czech Republic, in July 2009, where he presented “Physiologically Active Nanofibrin” and co-chaired a symposium entitled “Nanosensors and Nanomashines.”

Giora Netzer, MD, MSCE

Giora Netzer, MD, MSCE, assistant professor, Departments of Medicine and Epidemiology & Preventive Medicine, presented “Composite End Points: Considerations and Caveats” at the National Trauma Institute’s End Point Meeting in Houston, Texas, in September 2009.
Feyruz Rassool, PhD, associate professor, Department of Radiation Oncology and Program in Oncology, presented a talk at the European Society of Hematology Chronic Myeloid Leukemia Workshop in Bordeaux, France, in September 2009.

Lydia Temoshok, PhD

Lydia Temoshok

Lydia Temoshok, PhD, professor, Department of Medicine and Institute of Human Virology, gave an invited presentation entitled “Enhancing Performance by Appropriate Focus and Synchronized Response” at the Second Annual Frontiers in Psychoneuroimmunology Symposium on Emotions, the Immune System and Performance, at the University of South Florida, in Tampa, Florida, in September 2009.

Scott M. Thompson, PhD,
and Tom Blanpied, PhD


Scott Thompson
Scott M. Thompson, PhD (pictured), professor, and Tom Blanpied, PhD, assistant professor, both from the Department of Physiology, co-organized a workshop entitled “The Change We Need: New Frontiers in Live-Cell Imaging” at the Annual Meeting of the Society for Neuroscience in Chicago, Illinois, in October 2009. The workshop examined advanced microscopy approaches that push the limits of what is currently possible in the imaging of living cells and tissues, demonstrating techniques that have only recently become available to neuroscientists or that will only become available in the coming years.

Katherine Tkaczuk, MD

Katherine Tkaczuk

Katherine Tkaczuk, MD, professor, Department of Medicine, hosted the 7th Annual Breast Cancer Update in Baltimore in November 2009. This CME-accredited course featured lectures and panel discussions on the screening, diagnosis and current comprehensive multidisciplinary approaches in the treatment of breast cancer by University of Maryland School of Medicine faculty.

 
In Memoriam

Sergei P. Atamas, MD, PhD

Sergei Atamas

Sergei P. Atamas, MD, PhD, associate professor, Department of Medicine, along with his collaborator Dr. Lew C. Schon, an orthopedic surgeon at Union Memorial Hospital, were featured in a September 22, 2009, Baltimore Sun article entitled “Md., California Sign Agreement of Stem-Cell Research.” Drs. Atamas and Schon have been studying the value of stem cell injections in the healing of damaged or broken tendons in the foot with a $200,000 grant from the Maryland Stem Cell Research Fund. The study yielded positive results in that a large percentage of the patients healed more quickly and needed significantly less pain relief than is usual for this type of injury. The two are now investigating molecular mechanisms that mediate the healing action of stem cells on the tendon, with the goal of further perfecting this therapeutic approach. This ongoing study was presented at the World Stem Cell Summit held in Baltimore in September 2009.

Alan R. Shuldiner, MD

Alan Shuldiner

Alan R. Shuldiner, MD, John L. Whitehurst Professor of Medicine, was interviewed by WJZ TV’s Healthwatch reporter Kellye Lynn on August 26, 2009, about his article “Association of Cytochrome P450 2C19 Genotype with the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy,” which was published in the Journal of the American Medical Association (JAMA). In addition, he was interviewed and/or quoted regarding the JAMA article on August 25, 2009, by Reuters, Reuters Health, Science Daily, MedPage Today, HemOnc Today, TheHeart.Org and the London Telegraph and on August 26, 2009 by GenomeWeb Daily News, Genetic Engineering News and Health Day News. Also, Dr. Shuldiner was featured in the September 14, 2009, issue of The Lancaster New Era newspaper about his Amish Research Clinic in Lancaster, Pennsylvania.

 
New Faculty

Shad Baab, MD

Shad Baab, MD, joined the Department of Pediatrics as an assistant professor in July 2009. Dr. Baab received his MD from St. George’s University School of Medicine and then completed a pediatric residency at Brody School of Medicine at East Carolina University in Greenville, North Carolina, and a fellowship in pediatric emergency medicine at Akron Children’s Hospital. He certified by the American Board of Pediatrics.

Courtney L. Bui, MD, MSPH

Courtney Bui

Courtney L. Bui, MD, MSPH, joined the Department of Radiation Oncology as an assistant professor in September 2009. Dr. Bui received her medical degree from the University of North Carolina at Chapel Hill School of Medicine in 2002, then completed her internship at the Cleveland Clinic Foundation in 2003 and her radiation oncology residency at the University of Pennsylvania in 2007. Dr. Bui also has a master of science in public health from the University of North Carolina at Chapel Hill Gillings School of Global Public Health. Dr. Bui’s expertise is in brachytherapy and gynecologic cancers. She has extensive experience using all the latest radiation therapies, including intensity modulated radiation therapy, image-guided radiation therapy and stereotactic radiosurgery. Before coming to the University of Maryland, Dr. Bui practiced at St. Luke’s Hospital in Bethlehem, Pennsylvania, where she treated patients with a wide range of cancers.

Steven J. Feigenberg, MD

Steven Feigenberg

Steven J. Feigenberg, MD, joined the Department of Radiation Oncology as an associate professor in September 2009. He specializes in stereotactic body radiation therapy (SBRT) and will lead the Department of Radiation Oncology’s SBRT clinical, research and educational program. Dr. Feigenberg comes to Maryland after seven years at the Fox Chase Cancer Center in Philadelphia, where he was an associate professor. There he established the Stereotactic Radiosurgery/SBRT Program and was recognized as a Teacher of the Year award winner. He received his medical degree from Hahnemann University School of Medicine and completed his residency at the University of Florida in Gainesville.

 

Julie Kaplan, MD

Julie Kaplan

Julie Kaplan, MD, joined the Department of Pediatrics as an assistant professor in July 2009. Dr. Kaplan received her MD from the University of Maryland School of Medicine and then completed an internship and a residency in pediatrics at St. Louis Children’s Hospital/Washington University School of Medicine in St. Louis, Missouri. She recently completed a two-year residency in medical genetics at Stanford University in California and is certified by the American Board of Pediatrics.

 


Karl Prado, PhD

Karl Prado

Karl Prado, PhD, joined the Department of Radiation Oncology as an associate professor in October 2009. Dr. Prado will serve as associate chief of clinical physics of the Division of Medical Physics. In addition, he will oversee and coordinate all of the University of Maryland Marlene and Stewart Greenebaum Cancer Center’s community practices. Dr. Prado comes to Maryland from the University of Texas M.D. Anderson Cancer Center, where he was an associate professor of radiation physics for ten years and served as the deputy chief of Clinical Physics. He received his PhD from the University of Oklahoma Health Sciences Center.

 
Grants & Contracts

Robert J. Bloch, PhD

Robert Bloch

Robert J. Bloch, PhD, professor, Department of Physiology, received a two-year $758,231 research grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, under the American Recovery and Reinvestment Act of 2009. The grant is entitled “Intermediate Filaments & Costamere Structure & Function.”

Meredith Bond, PhD

Meredith Bond

Meredith Bond, PhD, professor and chair, Department of Physiology, received a one-year $276,723 competing supplement grant from the National Institute of Aging, under the American Recovery and Reinvestment Act of 2009. The parent grant is entitled “AKAP Regulation of PKA Targeting in the Heart.”

Gregory Carey, PhD

Gregory Carey

Gregory Carey, PhD, assistant professor, Department of Microbiology & Immunology and Center for Vascular and Inflammatory Diseases, received a one-year $100,000 National Cancer Institute grant for his work entitled “Selective Targeting of MEK and Akt in Lymphoma Myeloma Apoptosis.”

Yen-Pei Christy Chang, PhD

Christy Chang

Yen-Pei Christy Chang, PhD, assistant professor, Department of Medicine, received a two-year $627,400 R21 award from the National Institutes of Health for her work entitled “The Relationship between STK39, Salt Sensitivity, HCTZ-Induced BP Response.”

Kevin J. Cullen, MD

Kevin Cullen

Kevin J. Cullen, MD, professor, Department of Medicine, and director, University of Maryland Marlene and Stewart Greenebaum Cancer Center, received two administrative supplements to the Cancer Center Support Grant (P30). The first grant is for $1.5 million to hire a new physician-scientist for the period of August 1, 2009, to July 31, 2010, and the second is a two-year $150,000 supplement for pilot and grant programs to support developing shared services.

Reha Erzurumlu, PhD

Reha Erzurumlu

Reha Erzurumlu, PhD, professor, Department of Anatomy & Neurobiology, received a five-year $1,640,625 R01 competing renewal grant from the National Institute of Neurological Disorders and Stroke for “Cellular Mechanisms Underlying Pattern Formation.” Additionally, he received a $62,415 equipment supplement award from the National Institute of Neurological Disorders and Stroke for his R01 grant entitled “Somatosensory Cortical Development and Plasticity.”

Amy Fulton, PhD

Amy Fulton

Amy Fulton, PhD, Professor, Department of Pathology and Program in Oncology, received a three-year $775,750 Department of Defense grant for her work entitled “Reducing Breast Cancer Mortality by Targeting the COX-2 Pathway.”

Ronald Gartenhaus, MD

Ronald Gartenhaus

Ronald Gartenhaus, MD, associate professor, Departments of Medicine and Microbiology & Immunology and Program in Oncology, received a five-year $1,781,250 R01 grant from the National Institute on Alcohol Abuse and Alcoholism for his work entitled “Alcohol Consumption and Risk of NHL: Role of mTOR Dysfunction.”

Ann Gruber-Baldini, PhD

Ann Gruber-Baldini

Ann Gruber-Baldini, PhD, associate professor, Department of Epidemiology & Preventive Medicine, received a one-year $264,798 American Recovery and Reinvestment Act 2009 grant from the National Institutes of Health for her work entitled “FOCUS Hip Fracture Transfusion Trial: Delirium and Other Cognitive Outcomes.” The grant number is R01 HL085706-02S1.

Anne Hamburger, PhD

Anne Hamburger

Anne Hamburger, PhD, professor, Department of Pathology and Program in Oncology, received a two-year $930,338 National Cancer Institute grant for her work entitled “A Novel Therapy for HER2 Positive Hormone Refractory Breast Cancer.”

Bret Hassel, PhD

Bret Hassell

Bret Hassel, PhD, associate professor, Department of Microbiology & Immunology and Program in Oncology, received a two-year $750,000 National Institutes of Health grant for “Role of Antiviral Ribonuclease, RNase-L in the Host Antibacterial Response.”

Nicola Heller, PhD

Nicola Heller, PhD, post-doctoral fellow, Center for Vascular and Inflammatory Diseases, received an $870,574 career development K99/K00 award from the National Heart, Lung and Blood Institute for her work entitled “IRS Phosphorylation by Type I IL-4R Signaling Role in Allergic Disease” to support two years of her senior post-doctoral fellowship, followed by three years of portable R01 level funding to support the establishment of her own research program.

Frederick M. Ivey, PhD

Frederick Ivey

Frederick M. Ivey, PhD, assistant professor, Department of Medicine, received a three-year $718,100 VA Merit Award for “Strength Training for Skeletal Muscle Adaptation after Stroke.” In addition, Dr. Ivey, along with Marianne Shaughnessy, PhD, adjunct assistant professor, Department of Medicine, received a four-year $892,000 VA Merit Award for “Veterans with Stroke Translating Exercise Programs (VET STEP).”

Dhan V. Kalvakolanu, PhD

Dhan Kalvakolanu

Dhan V. Kalvakolanu, PhD, professor, Department of Microbiology & Immunology and Program in Oncology, received a five-year $280,989 administrative supplement to his National Cancer Institute R01 grant entitled “Cytokine Modulated Model Growth Inhibitory Mechanisms.”

Desiree Krebs-Kraft, PhD

Desiree Krebs-Kraft, PhD, post-doctoral fellow, Department of Physiology, received a two-year $100,000 post-doctoral fellowship from the Maryland Stem Cell Research Fund for “Endocannabinoids and Sex Differences in Human Neural Stem Cells.”

Stephen B. Liggett, MD

Stephen Liggett

Stephen B. Liggett, MD, professor, Departments of Medicine and Physiology, received a five-year $2.3 million grant from the National Heart, Lung and Blood Institute for his work on the molecular basis of rhinovirus-induced smooth muscle relaxation-contraction alterations. The title of his grant is “Lung HRV: G-Protein Coupled Signaling Interactions in Asthma.”

Tony Passaniti, PhD

Tony Passaniti, PhD, associate professor, Department of Pathology and Program in Oncology, received a two-year $154,000 American Heart Association grant for “Role of Hyperglycemia and Aldose Reductase in Regulating RUNX2 Transcription Factor Activity and Angiogenesis.”

Aaron Rapoport, MD

Aaron Rapoport

Aaron Rapoport, MD, professor, Department of Medicine and Program in Oncology, received a one-year $139,842 supplement to his National Cancer Institute R21 grant entitled “Immunotherapy after ASCT for MM Using hTERT Vaccination + Vaccine-Primed T Cells.”

Feyruz Rassool, PhD

Feyruz Rassool

Feyruz Rassool, PhD, associate professor, Department of Radiation Oncology and Program in Oncology, received a three-year $600,000 V Foundation grant for her work entitled “Targeting Abnormal DNA Repair Pathways in Leukemia.”

Douglas Ross, MD

Douglas Ross

Douglas Ross, MD, professor, Department of Medicine and Program in Oncology, received royalties for his invention entitled “Partial DNA & Deduced Protein Sequence of a Novel Member of the ATP-Binding Cassette Family of Transport Proteins that is Overexpressed in Human Multi-Drug Resistant Breast Carcinoma Cells.”

Alan R. Shuldiner, MD

Alan Shuldiner

Alan R. Shuldiner, MD, John L. Whitehurst Professor of Medicine, received a one-year $123,825 National Institutes of Health administrative supplement award for “Pharmacogenomics of CVD Risk Reduction;” a one-year $117,551 American Recovery and Reinvestment Act administrative supplement award for “Genetics of Diabetes in the Amish;” and two one-year American Recovery and Reinvestment Act administrative supplement awards totaling $352,096 for “Clinical Nutrition Research Unit of Maryland.”

Koji Tamada, MD

Koji Tamada, MD, associate professor, Department of Otorhinolaryngology-Head and Neck Surgery and Program in Oncology, received a two-year $273,614 American Recovery and Reinvestment Act supplement grant from the National Heart, Lung and Blood Institute for “Light Co-stimulatory Therapy of GVHD and GVL.”

Lydia Temoshok, PhD

Lydia Temoshock

Lydia Temoshok, PhD, professor, Department of Medicine and Institute of Human Virology, received an administrative supplement from the National Institute of Child Health and Development for a one-year extension of her five-year R01 grant entitled “Elucidating Biopsychosocial Factors Mediating HIV Progression.”

Jing Tian, MD, PhD

Jing Tian

Jing Tian, MD, PhD, research associate, Department of Medicine, received the 2009 Nuclear Cardiology Foundation Pilot and Feasibility Award from the American Society of Nuclear Cardiology. This one-year $30,000 study will investigate the feasibility of using PET bio-distributions in predicting electrophysiology voltage maps for ventricular tachycardia ablation.

Jaylyn Waddell, PhD

Jaylyn Waddell, PhD, post-doctoral fellow, Department of Physiology, received a two-year $100,000 post-doctoral fellowship from the Maryland Stem Cell Research Fund for “Androgens and Sex Differences in Human Neural Stem Cells.”

Da-Wei Gong, PhD

Da-Wei Gong, PhD, associate professor, Department of Medicine, received a two-year $230,000 award from the Maryland Technology Development Corporation for “Novel Vector Systems to Reprogram Human Adipose Stromal Vascular Cells Into Insulin-Producing Cells and Transplantable Adipocytes.”
 
Appointments

Vincent M. Conroy, PT, DScPT

Vinny Conroy

Vincent M. Conroy, PT, DScPT, assistant professor, Department of Physical Therapy & Rehabilitation Science, was appointed to the Maryland State Anatomy Board in September 2009. Dr. Conroy is the first physical therapist to ever be appointed to this board.

 

Ronald Gartenhaus, MD

Ronald Gartenhaus

Ronald Gartenhaus, MD, associate professor, Departments of Medicine and Microbiology & Immunology and Program in Oncology, has been appointed co-leader of the Molecular and Structural Biology Program in the University of Maryland Marlene and Stewart Greenebaum Cancer Center.

 

Steven R. Gambert, MD, MACP

Steven Gambert

Steven R. Gambert, MD, MACP, professor, Department of Medicine, and co-director, Division of Gerontology and Geriatric Medicine, was recently named president-elect of the Baltimore City Medical Society. He will assume this role following the organization’s Inauguration Gala on January 30, 2010. He will then assume the presidency of the Baltimore City Medical Society in January 2011. Dr. Gambert served as vice president of the medical society during 2009 and, since 2006, has been a member of their Board of Directors. Additionally, since 2004, he has served as chair of the Professional Education Committee. The society traces its roots back to 1788, and was formed to sustain quality medical practice, to serve the citizens of Baltimore, to advance the ethical practice of medicine and improve the quality of medical care by providing advocacy, educational programs and essential resources for physicians.

Lawrence Goldman, PhD

Lawrence Goldman

Lawrence Goldman, PhD, professor, Department of Physiology and Program in Neuroscience, was appointed to the rank of professor emeritus for his many years of dedicated teaching and scholarly service. Dr. Goldman received a plaque detailing his appointment at the November 2009 School of Medicine Council Meeting.

 

Koji Tamada, MD, PhD

Koji Tamada, MD, PhD, associate professor, Department of Otorhinolarynology-Head and Neck Surgery and Program in Oncology, has been appointed co-leader of the Tumor Immunology and Immunotheraphy Program in the University of Maryland Marlene and Stewart Greenebaum Cancer Center.

Ming T. Tan, PhD

Ming Tan

Ming T. Tan, PhD, professor, Department of Epidemiology & Preventive Medicine, has been appointed as the department’s new head of the Division of Biostatistics. Dr. Tan, who has been a member of the faculty since 2002, has extensive methodological and collaborative research in the design, conduct and analysis of clinical trials, laboratory investigations and epidemiologic research. Dr. Tan succeeds the division’s founding director Laurence S. Magder, PhD, professor, Department of Epidemiology & Preventive Medicine.

 

 

 
Honors

Angela Brodie, PhD

Angela Brodie

Angela Brodie, PhD, professor, Department of Pharmacology & Experimental Therapeutics, was one of 50 guests invited by First Lady Michelle Obama to attend a program honoring the millions of women and families affected by breast cancer. The program occurred October 23, 2009, on the grounds of the White House, in the Jacqueline Kennedy Gardens. The crowd consisted of survivors, lawmakers, physicians, researchers and officials from non-profit organizations, such as the National Breast Cancer Coalition and Susan G. Komen Foundation, who are dedicated to finding a cure for breast cancer. Speeches were given by Mrs. Obama, who focused on improving health care and reforming the US health care system; Jill Biden, EdD; and three women from the general public who shared their personal stories. The importance of early detection and increased access to preventive care was stressed.

Xiao-Ling Li, MD, PhD

Xiao-Ling Li, MD, PhD, research associate, Department of Microbiology & Immunology, received the 2009 Milstein Young Investigator Award from the International Society for Interferon and Cytokine Research (ISICR). The award was given at the October 2009 ISICR Annual Meeting in Lisbon, Portugal, where Dr. Li presented her work entitled “Reciprocal Regulation of Tristetraproline and RNase-L Modulates the Induction of Proinflammatory Cytokines.”

Allan Krumholz, MD

Alan Krumholz

Allan Krumholz, MD, professor, Department of Neurology, received the 11th Annual J. Kiffin Penry Award for Excellence in Epilepsy Care. The American Epilepsy Society (AES) developed this award as a tribute to J. Kiffin Penry, MD, and his many contributions to the treatment and study of epilepsy. Dr. Krumholz received the award at the 2009 AES Annual Meeting in Boston, Massachusetts, in December 2009. He was chosen in recognition of his genuine concern for patients, as well as his devotion to the care of people afflicted with epilepsy, characteristics reflective of Dr. Penry’s own philosophy.

Jing Tian, MD, PhD

Jing Tian

Jing Tian, MD, PhD, research associate, Department of Medicine, was named a finalist for the American Heart Association Young Investigator Award. She presented her research “Feasibility of Three Dimensional Anatomic, Dynamic and Perfusion Imaging of Myocardial Scar Using Contrast Enhanced Multi-Detector Computer Tomography to Guide Ventricular Tachycardia Ablations” at the American Heart Association 2009 Scientific Session in Orlando, Florida, in November 2009. Her research is the first application of 3D cardiac CT imaging in the field of cardiac electrophysiology and shows that integration of 3D CE-CT imaging allows an accurate, simultaneous display of left ventricular dynamic and anatomic characterization, which could be used to facilitate a novel image-guided approach to substrate-based VT ablations.

 
Copyright 2010 University of Maryland School of Medicine